BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6806416)

  • 81. [Influence of estrogens on pituitary responsiveness to LHRH and TRH in human (author's transl)].
    Lemarchand-Béraud T; Reymond M; Berthier C
    Ann Endocrinol (Paris); 1977; 38(6):379-82. PubMed ID: 417662
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of carbamazepine on pituitary responsiveness to luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide in epileptic patients.
    Isojärvi JI; Myllylä VV; Pakarinen AJ
    Epilepsia; 1989; 30(1):50-6. PubMed ID: 2492224
    [TBL] [Abstract][Full Text] [Related]  

  • 83. External pituitary irradiation as a cause of TRH deficiency in patients with pituitary adenomas.
    Macfarlane IA; Shalet SM; Beardwell CG; Applegate G; Robinson EL; Sutton ML
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):201-9. PubMed ID: 6406112
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [The effects of bromocriptine on anovulatory patients with high LH and euprolactinemia].
    Mori H; Aisaka K; Matsuoka R; Kigawa T
    Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):48-55. PubMed ID: 3922814
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Endocrinological evaluation of sellar and suprasellar tumor cases (the sixth report)-on pituitary hormone secretion of acromegalic patients before treatment (author's transl)].
    Watanabe M; Takimoto N; Mogami H; Hashimoto T; Ohnishi T
    No Shinkei Geka; 1976 May; 4(5):465-70. PubMed ID: 945479
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
    Brismar K
    Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prolactin: Physiology and pathology.
    Tolis G
    Hosp Pract; 1980 Feb; 15(2):85-95. PubMed ID: 6773874
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Role of prolactin in the regulation of sensitivity of the hypothalamic-pituitary system to steroid feedback.
    Bartke A; Matt KS; Steger RW; Clayton RN; Chandrashekar V; Smith MS
    Adv Exp Med Biol; 1987; 219():153-75. PubMed ID: 3324676
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Nonfunctioning pituitary macroadenoma presenting with mild hyperprolactinemia and amenorrhea.
    Hansen KA; Tho SP; Gomez F; McDonough PG
    Fertil Steril; 1999 Oct; 72(4):663-5. PubMed ID: 10521106
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease.
    Barbieri RL; Cooper DS; Daniels GH; Nathan D; Klibanski A; Ridgway EC
    Fertil Steril; 1985 Jan; 43(1):66-73. PubMed ID: 3917409
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [A recurrent case of TSH-PRL secreting microadenoma following hypothyroidism].
    Kurisaka M; Takei Y; Tindall GT
    No Shinkei Geka; 1986 Dec; 14(13):1569-75. PubMed ID: 3822056
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hyperprolactinemia in postmenopausal women.
    Maor Y; Berezin M
    Fertil Steril; 1997 Apr; 67(4):693-6. PubMed ID: 9093196
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [A case of male cystic pituitary adenoma with hyperprolactinemia--clinical study of 6 cases of male prolactinoma].
    Yatsuzuka H; Kitajima T; Taguchi Y; Sakai H; Nakamura N
    No Shinkei Geka; 1986 Dec; 14(13):1601-5. PubMed ID: 3822060
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [A case of pseudo-TSH.PRL-producing pituitary adenoma with secondary hypothyroidism].
    Koyama T; Shinoda S; Tani S; Kamikubo T; Nakamura N; Okuda M
    No To Shinkei; 1991 Feb; 43(2):187-91. PubMed ID: 1873088
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prolactin dynamics in a patient with isolated ACTH deficiency accompanied by hyperprolactinemia.
    Shibutani Y
    Am J Med Sci; 1988 Feb; 295(2):140-3. PubMed ID: 2830786
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma].
    Sabakhtarashvili MA; Veĭnberg EG; Kurashvili RB; Kanchaveli ZSh
    Akush Ginekol (Mosk); 1989 Oct; (10):50-4. PubMed ID: 2618957
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Basal and TRH-stimulated prolactin in patients with pituitary tumours.
    Lamberts SW; Birkenhäger JC; Kwa HG
    Clin Endocrinol (Oxf); 1976 Nov; 5(6):709-11. PubMed ID: 827399
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [A study with diagnostic standard of occult hyperprolactinemia (OHP) and the effect of bromocriptine administration].
    Aisaka K; Kaneda S; Tsuzuki H; Toriya Y; Kokuho K; Tamechika S; Saitoh H; Yoshida K; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):1017-27. PubMed ID: 8262272
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
    Maxson WS; Dudzinski M; Handwerger SH; Hammond CB
    Fertil Steril; 1984 Feb; 41(2):218-23. PubMed ID: 6698215
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [The effect of occult hyperprolactinemia (OHP) on gonadotropin secretion system].
    Aisaka K; Yoshida K; Kayama F; Kimura Y; Tamechika S; Satoh K; Matsuoka R; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1994 Dec; 70(10):1101-14. PubMed ID: 7859890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.